Back
Companhia Energética de Minas Gerais SA 10K Form
Sell
28
CIG
Companhia Energética de Minas Gerais SA
Last Price:
$2.03
Seasonality Move:
3.65%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CIG News And Ratings
See the #1 stock for the next 7 days that we like better than CIG
CIG Financial Statistics
Sales & Book Value
| Annual Sales: | $7.4B |
|---|---|
| Cash Flow: | $131.6M |
| Price / Cash Flow: | 9.96 |
| Annual Sales: | $1.89 |
| Price / Book: | 1.61 |
Profitability
| EPS (TTM): | 0.24620 |
|---|---|
| Net Income (TTM): | $704.4M |
| Gross Margin: | $1.4B |
| Return on Equity: | 14.05% |
| Return on Assets: | 6.27% |
Companhia Energética de Minas Gerais SA Earnings Forecast
Key Companhia Energética de Minas Gerais SA Financial Ratios
-
The Gross Profit Margin over the past 38 years for CIG is 19.26%.
-
The Selling, General & Administrative Expenses for CIG have been equal to 2.50% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 15.51% of Operating Income.
-
The Net Earning history of CIG is 17.88% of Total Revenues.
-
Per Share Earnings over the last 38 years have been positive in 12 years.
Companhia Energética de Minas Gerais SA Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Electric Utilities |
| Sector: | Utilities |
| Current Symbol: | CIG |
| CUSIP: | 204409 |
| Website: | ri.cemig.com.br |
Debt
| Debt-to-Equity Ratio: | 0.54 |
|---|---|
| Current Ratio: | 0.89 |
| Quick Ratio: | 0.67 |
Price-to-Earnings
| Trailing P/E Ratio: | 4.38 |
|---|---|
| Forward P/E Ratio: | 13.47 |
CIG Technical Analysis vs Fundamental Analysis
Sell
28
Companhia Energética de Minas Gerais SA (CIG)
is a Sell
Is Companhia Energética de Minas Gerais SA a Buy or a Sell?
-
Companhia Energética de Minas Gerais SA stock is rated a SellThe current Companhia Energética de Minas Gerais SA [CIG] share price is $2.02. The Score for CIG is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.